Institut für Ernährungswissenschaft
Refine
Year of publication
- 2015 (75) (remove)
Document Type
- Article (45)
- Doctoral Thesis (19)
- Conference Proceeding (4)
- Review (4)
- Postprint (2)
- Preprint (1)
Is part of the Bibliography
- yes (75)
Keywords
- Endothelin (3)
- Inflammation (2)
- Solanaceae (2)
- Sphingosine kinase (2)
- cells (2)
- coenzyme-a (2)
- database (2)
- energy-metabolism (2)
- glutathione (2)
- hallervorden-spatz-syndrome (2)
- inflammation (2)
- mobility-mass spectrometry (2)
- model (2)
- neurodegeneration (2)
- neurotoxicity (2)
- type 2 diabetes (2)
- 1-Phenylethanol (1)
- 2-Phenylethanol (1)
- 3,5-Dimethoxytoluene (1)
- ADPKD (1)
- AOAC (1)
- APOM protein (1)
- Abrus precatorius (1)
- Acid sphingomyelinase (1)
- Adipositas (1)
- Akt signaling (1)
- Alcohol dependence (1)
- Alkohol (1)
- Alpine metamorphism (1)
- Antibiotikaresistenz (1)
- Anxiety (1)
- Apoptosis (1)
- Arsenolipids (1)
- Aryl-hydrocarbon receptor (1)
- BMP4 (1)
- BPA (1)
- Beta-amylase (1)
- Bioaktivität (1)
- Bioavailability (1)
- Biomarker (1)
- Bisphenol A (1)
- Blood platelets (1)
- Brassicaceae (1)
- Caco-2 intestinal barrier model (1)
- Caenorhabditis elegans (1)
- Camellia sinensis (1)
- Cameroon (1)
- Cardiovascular (1)
- Carotenoid (1)
- Case-control study (1)
- Catechins (1)
- Ceramide (1)
- Chronic kidney disease (1)
- Clinical (1)
- Coagulation (1)
- Cognition (1)
- Colitis (1)
- Colon cancer (1)
- Connective tissue growth factor (1)
- Cyp2b1 (1)
- Cytotoxicity (1)
- DNA methylation (1)
- Darmbakterium (1)
- Dengue (1)
- Depression (1)
- Development (1)
- Diabetic cardiomyopathy (1)
- Diabetic nephropathy (1)
- Diagnostic (1)
- Dipeptidyl peptidase-4 inhibition (1)
- Disease (1)
- Doehlert design (1)
- Dopamine (1)
- Drug metabolism (1)
- ET-1 (1)
- ETA (1)
- ETB (1)
- Endocrine disruption (1)
- Endothelial cells (1)
- Endothelial dysfunction (1)
- Endothelial nitric oxide synthase (1)
- Epigenetic (1)
- Equol (1)
- Extraction (1)
- Fabaceae (1)
- Fibrosis (1)
- Firefly luciferase inhibition (1)
- Floral scent compound (1)
- Food Chain (1)
- Freeze-fracturing (1)
- Gastrointestinal tract (1)
- Gene expression (1)
- Geschmacksrezeptor (1)
- Glucagon (1)
- Glycerophospholipids (1)
- HEK293 (1)
- HPLC (1)
- Hepatotoxicity (1)
- High pressure - low temperature treatments (1)
- Host-plant suitability (1)
- Human (1)
- Human differentiated neurons (1)
- Hypoxia (1)
- IGF-1 (1)
- Insulin-induzierte Hypoglykämie (1)
- Isoflavone (1)
- Isotope-dilution analysis (1)
- Kinetik (1)
- Körpergewichsterhalt (1)
- Körpergewichtsverlust (1)
- Lebensmittelkette (1)
- Life science (1)
- Lipid (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Lu-Hf geochronology (1)
- Lysophosphatidylcholines (1)
- MRSA (1)
- Manganese (1)
- Mass spectrometry (1)
- Membrane (1)
- Menderes Massif (1)
- Mercuric mercury (1)
- Mesoangioblasts (1)
- Methylmercury (1)
- Mice (1)
- Micellar caseins (1)
- Microbial degradation (1)
- Migration (1)
- Model (1)
- Modell (1)
- Modelling (1)
- Morphogenesis (1)
- Motor coordination (1)
- Multiple herbivory (1)
- Myoblasts (1)
- Myzus persicae (1)
- Neurotoxicity (1)
- Nitric oxide (1)
- Nuclear receptor (1)
- Oxidative stress (1)
- PBPK (1)
- PBTK (1)
- Pea flour (1)
- Pea protein isolate (1)
- Pest infestation (1)
- Pest-pest interaction (1)
- Phenylpropanoids (1)
- Phosphatidylcholines (1)
- Phosphatidylinositols (1)
- Physicochemical properties (1)
- Plasma (1)
- Plasmalogens (1)
- Polymorphismus (1)
- Prediabetes (1)
- Presystemic metabolism (1)
- Procyanidins (1)
- Proteine (1)
- Pulmonary arterial hypertension (1)
- Purification (1)
- Pyrrolizidine alkaloids (1)
- QSAR (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- Reduktase (1)
- Relaxin (1)
- Resistance (1)
- Rezeptorscreening (1)
- Rosa x level (1)
- S1P(3) receptor (1)
- SU5416 (1)
- Serotonin (1)
- Short chain dehydrogenase (1)
- Solanum lycopersicum (1)
- Spectrophotometry (1)
- Sphingolipids (1)
- Sphingomyelin (1)
- Sphingosine 1phosphate (1)
- Structural changes (1)
- Süßgeschmack (1)
- Süßrezeptor (1)
- Süßstoff (1)
- TTC (1)
- Tandem mass spectrometry (1)
- Tas1r1 (1)
- Technofunctional properties (1)
- Tetranychus urticae (1)
- Thiomersal (1)
- Three phase partitioning (1)
- Thyroid hormone (1)
- ToF-SIMS imaging (1)
- Toxicity (1)
- Toxikokinetik (1)
- Transactivation assay (1)
- Transcriptomics (1)
- Transforming growth factor beta (1)
- Transmembrane asymmetry (1)
- Transmission (1)
- UDP-glucuronosyltransferase (1)
- Volatile compound (1)
- Whey proteins (1)
- Xenobesity (1)
- Yolk (1)
- acid sphingomyelinase (1)
- acute kidney injury (1)
- albuminuria (1)
- alcohol (1)
- aphids (1)
- atherosclerosis (1)
- auditory neurons (1)
- bioactivity (1)
- body weight loss (1)
- body weight maintenance (1)
- carotenoids (1)
- carotenoids bioavailability (1)
- ceramide (1)
- chronic kidney disease (1)
- crop (1)
- differentiation (1)
- equol (1)
- first trimester (1)
- garnet (1)
- genomics (1)
- gestational diabetes mellitus (GDM) (1)
- glucagon (1)
- glycaemic control (1)
- gut microbiota (1)
- high-density lipoprotein (HDL) (1)
- hypertension (1)
- iCheck (1)
- in silico (1)
- insulin (1)
- insulin-induced hypoglycemia (1)
- integrins (1)
- isoflavones (1)
- kidney dysfunction (1)
- kinetics (1)
- large for gestational age fetus (LGA) (1)
- linagliptin (1)
- metabolomics (1)
- microbiomics (1)
- micronutrient deficiencies (1)
- obesity (1)
- plant volatiles (1)
- platelets (1)
- polycystic kidney disease (1)
- polymorphism (1)
- proliferation (1)
- protein (1)
- protein microheterogeneity (1)
- proteomics (1)
- reductase (1)
- retinol (ROH) (1)
- serum amyloid A (SAA) (1)
- serum retinol binding protein (RBP4) (1)
- sphingolipids (1)
- sphingosine-1-phosphate (S1P) (1)
- spider mites (1)
- survival (1)
- sweet taste (1)
- sweet taste receptor (1)
- sweetener (1)
- systemic response (1)
- taste receptor (1)
- taste receptor screening (1)
- terpenoids (1)
- toxicology (1)
- transcriptomics (1)
- transthyretin (TTR) (1)
- tumor-metastasis (1)
- type 2 diabetes mellitus (1)
- umami (1)
- vitamin A deficiency (1)
- zinc/iron supplementation (1)
- Übertragung (1)
Institute
Background/Aims: In diabetic nephropathy (DN), the current angiotensin-II-blocking pharmacotherapy is frequently failing. For diabetic cardiomyopathy (DC), there is no specific remedy available. Relaxin-2 (Rlx) - an anti-fibrotic, anti-inflammatory, and vasoprotecting peptide - is a candidate drug for both. Methods: Low-dose (32 mu g/kg/day) and high-dose (320 mu g/kg/day) Rlx were tested against vehicle (n = 20 each) and non-diabetic controls (n = 14) for 12 weeks in a model of type-1 diabetes induced in endothelial nitric oxide synthase knock-out (eNOS-KO) mice by intraperitoneal injection of streptozotocin. Results: Diabetic animals showed normal plasma creatinine, markedly increased albuminuria and urinary malonyldialdehyde, elevated relative kidney weight, glomerulosclerosis, and increased glomerular size, but no relevant interstitial fibrosis. Neither dose of Rlx affected these changes although the drug was active and targeted plasma levels were achieved. Of note, we found no activation of the renal TGF-beta pathway in this model. In the hearts of diabetic animals, no fibrotic alterations indicative of DC could be determined which precluded testing of the initial hypothesis. Conclusions: We investigated a model showing early DN without overt tubulo-interstitial fibrosis and activation of the TGF-beta-Smad-2/3 pathway. In this model, Rlx proved ineffective; however, the same may not apply to other models and types of diabetes.
Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C-elegans
(2015)
cis-Diamminedichloroplatinum(II) (Cisplatin) is one of the most important and frequently used cytostatic drugs for the treatment of various solid tumors. Herein, a laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) method incorporating a fast and simple sample preparation protocol was developed for the elemental mapping of Cisplatin in the model organism Caenorhabditis elegans (C. elegans). The method allows imaging of the spatially-resolved elemental distribution of platinum in the whole organism with respect to the anatomic structure in L4 stage worms at a lateral resolution of 5 mm. In addition, a dose- and time-dependent Cisplatin uptake was corroborated quantitatively by a total reflection X-ray fluorescence spectroscopy (TXRF) method, and the elemental mapping indicated that Cisplatin is located in the intestine and in the head of the worms. Better understanding of the distribution of Cisplatin in this well-established model organism will be instrumental in deciphering Cisplatin toxicity and pharmacokinetics. Since the cytostatic effect of Cisplatin is based on binding the DNA by forming intra- and interstrand crosslinks, the response of poly(ADP-ribose) metabolism enzyme 1 (pme-1) deletion mutants to Cisplatin was also examined. Loss of pme-1, which is the C. elegans ortholog of human poly(ADP-ribose) polymerase 1 (PARP-1) led to disturbed DNA damage response. With respect to survival and brood size, pme-1 deletion mutants were more sensitive to Cisplatin as compared to wildtype worms, while Cisplatin uptake was indistinguishable.
Arsenic-containing fatty acids are a group of fat-soluble arsenic species (arsenolipids) which are present in marine fish and other seafood. Recently, it has been shown that arsenic-containing hydrocarbons, another group of arsenolipids, exert toxicity in similar concentrations comparable to arsenite although the toxic modes of action differ. Hence, a risk assessment of arsenolipids is urgently needed. In this study the cellular toxicity of a saturated (AsFA 362) and an unsaturated (AsFA 388) arsenic-containing fatty acid and three of their proposed metabolites (DMA(V), DMAPr and thio-DMAPr) were investigated in human liver cells (HepG2). Even though both arsenic-containing fatty acids were less toxic as compared to arsenic-containing hydrocarbons and arsenite, significant effects were observable at mu M concentrations. DMA(V) causes effects in a similar concentration range and it could be seen that it is metabolised to its highly toxic thio analogue thio-DMA(V) in HepG2 cells. Nevertheless, DMAPr and thio-DMAPr did not exert any cytotoxicity. In summary, our data indicate that risks to human health related to the presence of arsenic-containing fatty acids in marine food cannot be excluded. This stresses the need for a full in vitro and in vivo toxicological characterisation of these arsenolipids.
Background: Previous studies have shown that BMP4 may play an important part in the development of auditory neurons (ANs), which are degenerated in sensorineural hearing loss. However, whether BMP4 can promote sensory fate specification from mesenchymal stromal cells (MSCs) is unknown so far.
Methods: MSCs isolated from Sprague-Dawley (SD) rats were confirmed by expression of MSC markers using flow cytometry and adipogenesis/osteogenesis using differentiation assays. MSCs treated with a complex of neurotrophic factors (BMP4 group and non-BMP4 group) were induced into auditory neuron-like cells, then the differences between the two groups were analyzed in morphological observation, cell growth curve, qRT-PCR, and immunofluorescence.
Results: Flow cytometric analysis showed that the isolated cells expressed typical MSC surface markers. After adipogenic and osteogenic induction, the cells were stained by oil red O and Alizarin Red. The neuronal induced cells were in the growth plateau and had special forms of neurons. In the presence of BMP4, the inner ear genes NF-M, Neurog1, GluR4, NeuroD, Calretinin, NeuN, Tau, and GATA3 were up-regulated in MSCs.
Conclusions: MSCs have the capacity to differentiate into auditory neuron-like cells in vitro. As an effective inducer, BMP4 may play a key role in transdifferentiation.
Exposure to organic mercury compounds promotes primarily neurological effects. Although methylmercury is recognized as a potent neurotoxicant, its transfer into the central nervous system (CNS) is not fully evaluated. While methylmercury and thiomersal pass the blood-brain barrier, limited data are available regarding the second brain regulating interface, the blood-cerebrospinal fluid (CSF) barrier. This novel study was designed to investigate the effects of organic as well as inorganic mercury compounds on, and their transfer across, a porcine in vitro model of the blood-CSF barrier for the first time. The barrier system is significantly more sensitive towards organic Hg compounds as compared to inorganic compounds regarding the endpoints cytotoxicity and barrier integrity. Whereas there are low transfer rates from the blood side to the CSF side, our results strongly indicate an active transfer of the organic mercury compounds out of the CSF. These results are the first to demonstrate an efflux of organic mercury compounds regarding the CNS and provide a completely new approach in the understanding of mercury compounds specific transport.
Organic mercury (Hg) species exert their toxicity primarily in the central nervous system. The food relevant Hg species methylmercury (MeHg) has been frequently studied regarding its neurotoxic effects in vitro and in vivo. Neurotoxicity of thiomersal, which is used as a preservative in medical preparations, is to date less characterised. Due to dealkylation of organic Hg or oxidation of elemental Hg, inorganic Hg is present in the brain albeit these species are not able to readily cross the blood brain barrier. This study compared for the first time toxic effects of organic MeHg chloride (MeHgCl) and thiomersal as well as inorganic mercury chloride (HgCl2) in differentiated human neurons (LUHMES) and human astrocytes (CCF-STTG1). The three Hg species differ in their degree and mechanism of toxicity in those two types of brain cells. Generally, neurons are more susceptible to Hg species induced cytotoxicity as compared to astrocytes. This might be due to the massive cellular mercury uptake in the differentiated neurons. The organic compounds exerted stronger cytotoxic effects as compared to inorganic HgCl2. In contrast to HgCl2 exposure, organic Hg compounds seem to induce the apoptotic cascade in neurons following low-level exposure. No indicators for apoptosis were identified for both inorganic and organic mercury species in astrocytes. Our studies clearly demonstrate species-specific toxic mechanisms. A mixed exposure towards all Hg species in the brain can be assumed. Thus, prospectively coexposure studies as well as cocultures of neurons and astrocytes could provide additional information in the investigation of Hg induced neurotoxicity.
Inflammation in Cachexia
(2015)
Background/Aims: To investigate the renal phenotype under conditions of an activated renal ET-1 system in the status of nitric oxide deficiency, we compared kidney function and morphology in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxide synthase knockout (eNOS-/-) and ET+/+eNOS-/- mice. Methods: We assessed blood pressure, parameters of renal morphology, plasma cystatin C, urinary protein excretion, expression of genes associated with glomerular filtration barrier and tissue remodeling, and plasma metabolites using metabolomics. Results: eNOS-/- and ET+/+eNOS-/- mice developed hypertension. Osteopontin, albumin and protein excretion were increased in eNOS-/- and restored in ET+/+eNOS-/- animals. All genetically modified mice developed renal interstitial fibrosis and glomerulosclerosis. Genes involved in tissue remodeling (serpinel, TIMP1, Collal, CCL2) were up-regulated in eNOS-/-, but not in ET+/+eNOS-/- mice. Plasma levels of free carnitine and acylcarnitines, amino acids, diacyl phosphatidylcholines, lysophosphatidylcholines and hexoses were descreased in eNOS-/- and were in the normal range in ET+/+eNOS-/- mice. Conclusion: eNOS-/- mice developed renal dysfunction, which was partially rescued by ET-1 overexpression in eNOS-/- mice. The metabolomics results suggest that ET-1 overexpression on top of eNOS knockout is associated with a functional recovery of mitochondria (rescue effect in 13-oxidation of fatty acids) and an increase in antioxidative properties (normalization of monounsaturated fatty acids levels). (C) 2015 The Author(s) Published by S. Karger AG, Basel
The matricellular protein connective tissue growth factor (CTGF/CCN2) is recognized as key player in the onset of fibrosis in various tissues, including skeletal muscle. In many circumstances, CTGF has been shown to be induced by transforming growth factor beta (TGF beta) and accounting, at least in part, for its biological action. In this study it was verified that in cultured myoblasts CTGF/CCN2 causes their transdifferentiation into myofibroblasts by up-regulating the expression of fibrosis marker proteins alpha-smooth muscle actin and transgelin. Interestingly, it was also found that the profibrotic effect exerted by CTGF/CCN2 was mediated by the sphingosine kinase (SK)-1/S1P(3) signaling axis specifically induced by the treatment with the profibrotic cue. Following CTGF/CCN2-induced up-regulation, S1P(3) became the SIP receptor subtype expressed at the highest degree, at least at mRNA level, and was thus capable of readdressing the sphingosine 1-phosphate signaling towards fibrosis rather than myogenic differentiation. Another interesting finding is that CTGF/CCN2 silencing prevented the TGF beta-dependent up-regulation of SKI/S1P(3) signaling axis and strongly reduced the profibrotic effect exerted by TGF beta, pointing at a crucial role of endogenous CTGF/CCN2 generated following TGF beta challenge in the transmission of at least part of its profibrotic effect These results provide new insights into the molecular mechanism by which CTGF/CCN2 drives its biological action and strengthen the concept that SK1/S1P(3) axis plays a critical role in the onset of fibrotic cell phenotype. (C) 2014 Elsevier B.V. All rights reserved.
2-Phenylethanol (2PE) and 3,5-dimethoxytoluene (DMT) are characteristic scent compounds in specific roses such as Rosa x hybrida cv. 'Yves Piaget'. We analyzed the endogenous concentrations and emission of 2PE and DMT during the unfurling process in different floral organs, as well as changes in transcript levels of the two key genes, PAR and OOMT2.
The emission of both 2PE and DMT increased during floral development to reach peaks at the fully unfurled stage. The relative transcripts of PAR and OOMT2 also increased during floral development. Whereas the maximum for OOMT2 was found at the fully unfurled stage (stage 4), similar expression levels of PAR were detected at stage 4 and the senescence stage (stage 6). The results demonstrate a positive correlation between the expression levels of PAR and OOMT2 and the emission of 2PE and DMT. In addition, endogenous volatiles and relative transcripts showed tissue- and development-specific patterns. (C) 2014 Elsevier Masson SAS. All rights reserved.
Pak Choi Fed to Mice: Formation of DNA Adducts and Influence on Xenobiotic-Metabolizing Enzymes
(2015)
Xenobiotics may interfere with the hypothalamic-pituitary-thyroid endocrine axis by inducing enzymes that inactivate thyroid hormones and thereby reduce the metabolic rate. This induction results from an activation of xeno-sensing nuclear receptors. The current study shows that benzo[a]pyrene, a frequent contaminant of processed food and activator of the arylhydrocarbon receptor (AhR) activated the promoter and induced the transcription of the nuclear receptor constitutive androstane receptor (CAR, NR1I3) in rat hepatocytes. Likewise, phenobarbital induced the AhR transcription. This mutual induction of the nuclear receptors enhanced the phenobarbital-dependent induction of the prototypic CAR target gene Cyp2b1 as well as the AhR-dependent induction of UDP-glucuronosyltransferases. In both cases, the induction by the combination of both xenobiotics was more than the sum of the induction by either substance alone. By inducing the AhR, phenobarbital enhanced the benzo[a]pyrene-dependent reduction of thyroid hormone half-life and the benzo[a]pyrene-dependent increase in the rate of thyroid hormone glucuronide formation in hepatocyte cultures. CAR ligands might thus augment the endocrine disrupting potential of AhR activators by an induction of the AhR. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
A novel common variant in DCST2 is associated with length in early life and height in adulthood
(2015)
Common genetic variants have been identified for adult height, but not much is known about the genetics of skeletal growth in early life. To identify common genetic variants that influence fetal skeletal growth, we meta-analyzed 22 genome-wide association studies (Stage 1; N = 28 459). We identified seven independent top single nucleotide polymorphisms (SNPs) (P < 1 x 10(-6)) for birth length, of which three were novel and four were in or near loci known to be associated with adult height (LCORL, PTCH1, GPR126 and HMGA2). The three novel SNPs were followed-up in nine replication studies (Stage 2; N = 11 995), with rs905938 in DC-STAMP domain containing 2 (DCST2) genome-wide significantly associated with birth length in a joint analysis (Stages 1 + 2; beta = 0.046, SE = 0.008, P = 2.46 x 10(-8), explained variance = 0.05%). Rs905938 was also associated with infant length (N = 28 228; P = 5.54 x 10(-4)) and adult height (N = 127 513; P = 1.45 x 10(-5)). DCST2 is a DC-STAMP-like protein family member and DC-STAMP is an osteoclast cell-fusion regulator. Polygenic scores based on 180 SNPs previously associated with human adult stature explained 0.13% of variance in birth length. The same SNPs explained 2.95% of the variance of infant length. Of the 180 known adult height loci, 11 were genome-wide significantly associated with infant length (SF3B4, LCORL, SPAG17, C6orf173, PTCH1, GDF5, ZNFX1, HHIP, ACAN, HLA locus and HMGA2). This study highlights that common variation in DCST2 influences variation in early growth and adult height.
Characterization of freeze-fractured epithelial plasma membranes on nanometer scale with ToF-SIMS
(2015)
Time-of-flight secondary ion mass spectrometry (ToF-SIMS) was used to characterize the freeze-fracturing process of human epithelial PANC-1 and UROtsa cells. For this purpose, phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, and phosphatidylserine standard samples were investigated to find specific signals with both high specificity and signal intensity. The results were used to investigate single cells of subconfluent cell layers prepared with a special silicon wafer sandwich preparation technique. This freeze-fracturing technique strips cell membranes off the cells, isolating them on opposing silicon wafer substrates. Criteria were found for defining regions with stripped off cell membranes and, on the opposing wafer, complementary regions with the remaining cells. Measured ethanolamine/choline and serine/choline ratios in these regions clearly showed that in the freeze-fracturing process, the lipid bilayer of the plasma membrane is split along its central zone. Accordingly, only the outer lipid monolayer is stripped off the cell, while the inner lipid monolayer remains attached to the cell on the opposing wafer, thus allowing detailed analysis of a single lipid monolayer. Furthermore, it could be shown that using different washing procedures did not influence the transmembrane lipid distribution. Under optimized preparation conditions, it became feasible to detect lipids with a lateral resolution of approximately 100 nm. The data indicate that ToF-SIMS would be a very useful technique to study with very high lateral resolution changes in lipid composition caused, for example, by lipid storage diseases or pharmaceuticals that interfere with the lipid metabolism.
All components of the endothelin (ET) system are present in renal tubular cells. In this review, we summarize current knowledge about ET and the most common tubular diseases: acute kidney injury (AKI) and polycystic kidney disease. AKI originally was called acute tubular necrosis, pointing to the most prominent morphologic findings. Similarly, cysts in polycystic kidney disease, and especially in autosomal-dominant polycystic kidney disease, are of tubular origin. Preclinical studies have indicated that the ET system and particularly ETA receptors are involved in the pathogenesis of ischemia-reperfusion injury, although these findings have not been translated to clinical studies. The ET system also has been implicated in radiocontrast-dye-induced AKI, however, ET-receptor blockade in a large human study was not successful. The ET system is activated in sepsis models of AKI; the effectiveness of ET blocking agents in preclinical studies is variable depending on the model and the ET-receptor antagonist used. Numerous studies have shown that the ET system plays an important role in the complex pathophysiology associated with cyst formation and disease progression in polycystic kidney disease. However, results from selective targeting of ET-receptor subtypes in animal models of polycystic kidney disease have proved disappointing and do not support clinical trials. These studies have shown that a critical balance between ETA and ETB receptor action is necessary to maintain structure and function in the cystic kidney. In summary, ETs have been implicated in the pathogenesis of several renal tubulointerstitial diseases, however, experimental animal findings have not yet led to use of ET blockers in human beings. (C) 2015 Elsevier Inc. All rights reserved.